347 related articles for article (PubMed ID: 12920414)
41. Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.
Koethe D; Juelicher A; Nolden BM; Braunwarth WD; Klosterkötter J; Niklewski G; Wodarz N; Klatt J; Burtscheidt W; Gaebel W; Markus Leweke F
Alcohol Clin Exp Res; 2007 Jul; 31(7):1188-94. PubMed ID: 17511748
[TBL] [Abstract][Full Text] [Related]
42. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.
Walsh JK; Perlis M; Rosenthal M; Krystal A; Jiang J; Roth T
J Clin Sleep Med; 2006 Jan; 2(1):35-41. PubMed ID: 17557435
[TBL] [Abstract][Full Text] [Related]
43. The effect of placebo administration on the first-night effect in healthy young volunteers.
Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
[TBL] [Abstract][Full Text] [Related]
44. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
[TBL] [Abstract][Full Text] [Related]
45. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
Rosenberg R; Caron J; Roth T; Amato D
Sleep Med; 2005 Jan; 6(1):15-22. PubMed ID: 15680290
[TBL] [Abstract][Full Text] [Related]
46. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
48. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
Braam W; Didden R; Smits M; Curfs L
J Intellect Disabil Res; 2008 Mar; 52(Pt 3):256-64. PubMed ID: 18261024
[TBL] [Abstract][Full Text] [Related]
49. Sleep complaints: Whenever possible, avoid the use of sleeping pills.
Prescrire Int; 2008 Oct; 17(97):206-12. PubMed ID: 19536941
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
51. Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial.
Friedmann PD; Rose JS; Swift R; Stout RL; Millman RP; Stein MD
Alcohol Clin Exp Res; 2008 Sep; 32(9):1652-60. PubMed ID: 18616688
[TBL] [Abstract][Full Text] [Related]
52. Long-term changes in sleep and depressive symptoms of smokers in abstinence.
Moreno-Coutiño A; Calderón-Ezquerro C; Drucker-Colín R
Nicotine Tob Res; 2007 Mar; 9(3):389-96. PubMed ID: 17365770
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
54. Trazodone: alternative dose regimens and sleep.
Wheatley D
Pharmatherapeutica; 1984; 3(9):607-12. PubMed ID: 6374681
[TBL] [Abstract][Full Text] [Related]
55. Pharmacodynamics of temazepam in primary insomnia: assessment of the value of quantitative electroencephalography and saccadic eye movements in predicting improvement of sleep.
Tuk B; Oberyé JJ; Pieters MS; Schoemaker RC; Kemp B; van Gerven J; Danhof M; Kamphuisen HA; Cohen AF; Breimer DD; Peck CC
Clin Pharmacol Ther; 1997 Oct; 62(4):444-52. PubMed ID: 9357396
[TBL] [Abstract][Full Text] [Related]
56. Patients with insomnia and subthreshold depression show marked worsening of insomnia after discontinuation of sleep promoting medication.
Wichniak A; Wierzbicka A; Jernajczyk W
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1671-6. PubMed ID: 21723905
[TBL] [Abstract][Full Text] [Related]
57. Halazepam in the management of acute alcohol withdrawal syndrome.
Mendels J; Wasserman TW; Michals TJ; Fine EW
J Clin Psychiatry; 1985 May; 46(5):172-4. PubMed ID: 2859274
[TBL] [Abstract][Full Text] [Related]
58. An observational study of insomnia and nightmare treated with trazodone in patients with advanced cancer.
Tanimukai H; Murai T; Okazaki N; Matsuda Y; Okamoto Y; Kabeshita Y; Ohno Y; Tsuneto S
Am J Hosp Palliat Care; 2013 Jun; 30(4):359-62. PubMed ID: 22777411
[TBL] [Abstract][Full Text] [Related]
59. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study.
Jacobsen FM
J Clin Psychiatry; 1990 Jul; 51(7):298-302. PubMed ID: 2365668
[TBL] [Abstract][Full Text] [Related]
60. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial.
Khazaie H; Ghadami MR; Knight DC; Emamian F; Tahmasian M
Psychiatry Res; 2013 Dec; 210(3):901-5. PubMed ID: 23993464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
